# Trial to Evaluate the Hemostatic Effect of Lyostypt® Versus Surgicel® in Arterial Bypass Anastomosis

> **NCT00837954** · PHASE4 · COMPLETED · sponsor: **Aesculap AG** · enrollment: 32 (actual)

## Conditions studied

- Peripheral Vascular Diseases
- Hemostasis

## Interventions

- **DEVICE:** Lyostypt® AND Surgicel®
- **DEVICE:** Lyostypt®
- **PROCEDURE:** Surgicel®

## Key facts

- **NCT ID:** NCT00837954
- **Lead sponsor:** Aesculap AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2009-12
- **Final completion:** 2010-04
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2015-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00837954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00837954, "Trial to Evaluate the Hemostatic Effect of Lyostypt® Versus Surgicel® in Arterial Bypass Anastomosis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00837954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*